ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,792Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 769

$624K Total Retail Price of All Prescriptions

Rank: 117 out of 769

330 Patients Receiving at Least One Drug in Part D
62% Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 330 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

54% of this provider’s 330 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $121 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 698 357 136 S3 1 15
FUROSEMIDE 671 446 121 2 2
LOSARTAN POTASSIUM 421 296 74 3 6
METOPROLOL TARTRATE 383 282 67 4 9
ACETAMINOPHEN-CODEINE 331 201 57 S3 5 96
CLONIDINE HCL 330 215 50 6 17
SIMVASTATIN 301 202 44 7 5
CARISOPRODOL 282 89 53 R 8 188
AMLODIPINE BESYLATE 267 172 41 9 1
DIOVAN 266 180 42 10 19
DIAZEPAM 246 148 44 B 11 212
NIFEDIPINE ER 218 161 34 12 20
ATORVASTATIN CALCIUM 207 128 40 13 10
PROAIR HFA 205 147 45 14 82
POTASSIUM CHLORIDE 204 159 37 15 37
CRESTOR 202 157 45 16 41
OMEPRAZOLE 199 120 34 17 8
METFORMIN HCL 188 116 28 18 22
CARVEDILOL 186 140 36 19 11
TRAMADOL HCL 182 149 46 20 44
LISINOPRIL 182 122 32 20 4
TAMSULOSIN HCL 152 119 24 22 25
CLOPIDOGREL 135 103 20 23 26
LEVOTHYROXINE SODIUM 131 117 22 24 13
RENVELA 126 44 19 25 3
ZOLPIDEM TARTRATE 126 39 25 25 29
GLYBURIDE 111 52 19 R 27 158
GLIPIZIDE 106 55 17 28 32
PHENYTOIN SODIUM EXTENDED 100 42 11 29 271
TEMAZEPAM 97 66 25 B 30 107
LORAZEPAM 97 54 27 B 30 54
DONEPEZIL HCL 97 92* 14 30 49
PANTOPRAZOLE SODIUM 96 73 23 33 31
IBUPROFEN 95 42 18 34 109
LEVOFLOXACIN 93 57 59 35 74
VALSARTAN-HYDROCHLOROTHIAZIDE 79 64 13 36 80
ADVAIR DISKUS 77 47 11 37 93
AZITHROMYCIN 76 52 53 38 63
LYRICA 74 44 17 39 101
VENTOLIN HFA 72 39 18 40 294
ATENOLOL 71 <11 <11 41 23
ALPRAZOLAM 68 19 13 B 42 61
MEGESTROL ACETATE 68 42 25 R 42 71
ENALAPRIL MALEATE 66 <11 <11 44 66
GABAPENTIN 64 45 14 45 21
AVODART 60 48 14 46 90
DEXILANT 60 27 14 46 70
HYDROCHLOROTHIAZIDE 59 27 15 48 27
BENICAR 57 <11 <11 49 79
KLOR-CON 8 55 <11 <11 50 190
WARFARIN SODIUM 54 35 11 51 33
JANUVIA 52 <11 <11 52 35
AMITRIPTYLINE HCL 51 <11 <11 R 53 156
ALLOPURINOL 51 46* 11 53 12
DILAUDID 50 <11 <11 S2 10 55 392
TERAZOSIN HCL 50 <11 <11 55 56
OXYCODONE HCL 50 <11 <11 S2 55 208
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.